Clinical Trials Directory

Trials / Completed

CompletedNCT06173856

Effectiveness of Phototherapy With and Without Probiotics

Effectiveness of Phototherapy With and Without Probiotics for the Treatment of Indirect Hyperbilirubinemia in Preterm Neonates

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
76 (actual)
Sponsor
Fatima Jinnah Medical University · Academic / Other
Sex
All
Age
0 Hours – 1 Week
Healthy volunteers
Not accepted

Summary

Raised serum bilirubin levels can cause kernicterus and premature infants are at increased risk due to metabolic immaturity. The standard treatment for neonatal jaundice is phototherapy but probiotics along with it can reduce the duration of phototherapy and hospitalization stay, secondarily can reduce the risk of nosocomial infection.

Detailed description

Raised serum bilirubin levels can cause kernicterus and premature infants are at increased risk due to metabolic immaturity. The comparative analytical study was conducted after the ethical approval for one year (Jan 2022-Jan 2023) in the neonatal unit of The University of Lahore Teaching Hospital, Lahore, Pakistan. 76 preterm neonates fulfilling the selection criteria were included in the study and divided into two groups. Standard phototherapy was applied in both groups and group A probiotic (Saccharomyces boulardii) 125mg, twice daily, orally (in 5cc of milk whichever the baby was taking) was given till discharge from the hospital. The primary outcome measurements were the duration of phototherapy and the length of hospitalization.

Conditions

Interventions

TypeNameDescription
OTHERLED phototherapyLED phototherapy (430-470nm) alone will be applied.

Timeline

Start date
2022-01-10
Primary completion
2022-10-10
Completion
2023-01-15
First posted
2023-12-18
Last updated
2023-12-18

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06173856. Inclusion in this directory is not an endorsement.